Non-Invasive and Rapid Coronary Artery Disease Diagnosis with VCAST: Medicalgorithmics Prepares for Commercialization of New AI Technology
VCAST is a technology developed by the American company Kardiolytics, part of the Medicalgorithmics Group, enabling non-invasive, quick, and accurate diagnosis of coronary artery disease. The product is nearing commercialization. The CE certification process is in its final stage, the company has signed its first contract to use VCAST in a research project, and is in discussions with additional medical centers interested in collaboration.